1.
Konstantin Byrgazov, Chantal Blanche Lucini, Peter Valent, Oliver Hantschel, Thomas Lion. BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib. haematol [Internet]. 2018Jan.1 [cited 2022Sep.29];103(1):e10-e12. Available from: https://haematologica.org/article/view/8329